A group of researchers at Johns Hopkins hospital released a report on July 31st, 2007, announcing success in genetically engineering mice with Schizophrenia, a breakthrough that could help researchers understand the disorder better and develop new treatments.
Until now, antipsychotic drugs used to treat Schizophrenia were often tested on
mice who had received mind-altering drugs such as LSD or PCP. This new strain of mice, however, make much better test subjects since they actually carry a gene (DISC1) isolated in a Scottish family known to be prone to the illness; this gene has been found in several other families in other countries as well, making it likely that the mutation plays some role in Schizophrenia.
These new rats show many of the behavioral traits of humans with Schizophrenia (odd behaviors, difficulty with memory, etc.), and react well when treated with current antipsychotics.
To read more about this report, CLICK HERE.











